Infrasonic Stethoscope for Monitoring Physiological Processes by Zuckerwar, Allan J. et al.
1111111111111111111inuuu1111111111u~
(12) United States Patent
Shams et al.
(54) INFRASONIC STETHOSCOPE FOR
MONITORING PHYSIOLOGICAL
PROCESSES
(71) Applicant: The United States of America as
represented by the Administrator of
the National Aeronautics and Space
Administration, Washington, DC (US)
(72) Inventors: Qamar A. Shams, Yorktown, VA (US);
Allan J. Zuckerwar, Williamsburg, VA
(US); Albert L. Dimarcantonio,
Williamsburg, VA (US)
(73) Assignee: The United States of America as
Represented by the Adminstrator of
NASA, Washington, DC (US)
(*) Notice: Subject to any disclaimer, the term of this
patent is extended or adjusted under 35
U.S.C. 154(b) by 0 days.
This patent is subject to a terminal dis-
claimer.
(21) Appl. No.: 15/244,517
(22) Filed: Aug. 23, 2016
(65) Prior Publication Data
US 2016/0354055 Al Dec. 8, 2016
Related U.S. Application Data
(63) Continuation of application No. 14/658,584, filed on
Mar. 16, 2015, now Pat. No. 9,445,779.
(Continued)
(51) Int. Cl.
A61B 7/04 (2006.01)
A61B 8/08 (2006.01)
(Continued)
(io) Patent No.: US 9,867,591 B2
(45) Date of Patent: *Jan.16, 2018
(52) U.S. Cl.
CPC ................ A61B 7/04 (2013.01); A61B 7/023
(2013.01); A61B 8/0883 (2013.01); H04R
1/46 (2013.01)
(58) Field of Classification Search
CPC .......... A61B 7/04; A61B 8/0883; H04R 1/08;
H04R 2410/00
See application file for complete search history.
(56) References Cited
U.S. PATENT DOCUMENTS
3,247,324 A * 4/1966 Cefaly ..................... A61B 7/02
181/131
3,550,720 A * 12/1970 Ballard .................. H04R 1/086
181/175
(Continued)
FOREIGN PATENT DOCUMENTS
WO WO 0209586 A2 * 2/2002 ............... A61B 7/04
Primary Examiner Brenda Bernardi
(74) Attorney, Agent, or Firm Andrea Z. Warmbier;
Robin W. Edwards; Mark P. Dvorscak
(57) ABSTRACT
An infrasonic stethoscope for monitoring physiological pro-
cesses of a patient includes a microphone capable of detect-
ing acoustic signals in the audible frequency bandwidth and
in the infrasonic bandwidth (0.03 to 1000 Hertz), a body
coupler attached to the body at a first opening in the
microphone, a flexible tube attached to the body at a second
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INFRASONIC STETHOSCOPE FOR
MONITORING PHYSIOLOGICAL
PROCESSES
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STATEMENT REGARDING FEDERALLY 15
SPONSORED RESEARCH OR DEVELOPMENT
The invention described herein was made in the perfor-
mance of work under a NASA contract and by employees of
the United States Government and is subject to the provi- 20
sions of Public Law 96-517 (35 U.S.C. §202) and may be
manufactured and used by or for the Government for gov-
ernmental purposes without the payment of any royalties
thereon or therefore. In accordance with 35 U.S.C. §202, the
contractor elected not to retain title. 25
FIELD OF THE INVENTION
The present disclosure relates to an infrasonic stethoscope
(or "infrascope") for monitoring physiological processes 30
and is particularly related to a wireless infrasonic stetho-
scope.
BACKGROUND OF THE INVENTION
35
Sound at frequencies below 20 Hertz is termed "infra-
sound." A particularly favorable property of infrasound is its
propagation over long distances with little attenuation.
Ultrasound has this property because atmospheric absorp-
tion is practically negligible at infrasonic frequencies, and 40
because there is an acoustic "ceiling" in the stratosphere
where a positive gradient of the speed of sound versus
altitude causes reflections of infrasonic rays back to Earth.
Infrasound propagation over long distances (e.g., thousands
of kilometers) is predominantly due to refractive ducting 45
from the upper layers in the atmosphere, while propagation
over short distances is completed by direct path.
The density, acoustic impedance, and speed of sound
through different human and animal tissues varies depending
upon location of the auscultation. When an acoustic signal 50
travels through tissue layers, the amplitude of the original
signal becomes more attenuated with depth of the acoustic
signal source. Attenuation (i.e. energy loss) could be due to
absorption, reflection, and scattering at interfaces of differ-
ent tissues. The degree of attenuation also depend upon 55
frequency of the sound wave and the distance it travels.
Generally speaking, a high frequency acoustic signal is
associated with high attenuation thus limiting tissue pen-
etration, but lower frequencies do not have attenuation issue
thus providing physicians better understanding of the heart 60
performance. More than 60% power spectral density of heart
signals fall in infrasonic bandwidth. Low frequency acoustic
signals detected from different human organs, such as the
heart, are valuable to physicians for monitoring heart and
lungs. 65
Microphones and stethoscopes are regularly used by
physicians in detecting sounds for monitoring physiological
2
conditions. Phonocardiography has been in use for more
than 75 years to monitor heart beats as well as to detect the
audible sound of the blood flowing through the heart. These
physiological condition monitors are coupled directly to a
person's body and processes are measured either by listen-
ing or by recording the signals in certain bandwidth. The
physiological processes such as respiration and cardiac
activity are reflected in a different frequency bandwidth
from'/io Hertz to 500 Hertz. Other stethoscopes are capable
of monitoring only audible frequency bandwidth, and are
not capable of monitoring infrasonic frequencies below 20
Hz. Low frequency acoustic signals below 20 Hertz are not
audible, but can provide useful information to physicians.
Inside of a normal heart, there are four chambers namely;
the right atrium, the left atrium, the right ventricle, and the
left ventricle. The function of a heart is to keep blood
flowing in one-way direction. When a valve opens, the valve
lets the right amount of blood through, and then closes to
keep blood from flowing backwards in between beats. An
easy and relatively inexpensive assessment of any patient's
cardiac status can be determined by sounds in the chest. The
key to good auscultation ties in low and high pitched sounds.
As the heart beats, blood flows from right atrium into the
right ventricle through the tricuspid valve.
Blood then flows to the lungs through pulmonary valve
(sometimes also called semilunar valve) to pick up right
amount of oxygen. The blood flows from the lungs back into
the left atrium and enters into the left ventricle through the
mitral valve. Blood then is pumped to the aorta through the
aortic valve and goes out to rest of the body providing
oxygen and nutrients to the body cells. All four chambers
(right atrium, right ventricle, left atrium, and left ventricle)
must contract at just the right time for normal heart to
functioning properly. The proper timing is coordinated by
heart's electrical pathways. The electrical signals are pro-
duced by the sinoatrial node (SA node) and atrioventricular
node (AV node).
The SA node is a group of cells located in the right atrium
that initiates contraction of both atria to push blood into their
corresponding ventricles. Due to insulation between the atria
and ventricles, the SA node signals do not continue directly
to the ventricles but pass through the AV node, which is
another group of cells located in the floor of right atrium
between the atria and ventricles. The AV node regulates the
signal to ensure that the atria are empty and closed before the
ventricles contract to push the blood out of the heart. The SA
node sends signals to stimulate the heart to beat between
60-100 times per minute.
The cardiovascular system is complex and numerous
problems could take place inside anywhere from the elec-
trical system of the heart to the large or small blood vessels.
There are over 60 different types of cardiovascular disease,
all of which somehow affect the cardio or vascular systems.
The heart sounds generated by the beating of heart and the
resultant flow of blood can provide important information
about the condition of the heart. In healthy adults, two
normal heart sounds occur in sequence with the heartbeat. A
first sound is produced based on the closure of the atrioven-
tricular valves (i.e. mitral and tricuspid valves) located
between the atria and ventricles, and is referred to as S1. A
second sound is produced as a result of closure of the
semilunar valves (i.e. pulmonary and aortic valves), which
control the flow of blood as it leaves the heart via the
arteries, and is referred to as S2.
The first heart sound S1 consists of four sequential
components: 1. Small low frequency vibrations that coincide
with the beginning of left ventricular contraction. 2. High
US 9,867,591 B2
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frequency vibration, easily audible related to mitral valve
closure (MI). 3. A second high frequency component related
to tricuspid valve closure, 4. Small frequency vibrations that
coincide with the acceleration of blood into great vessel.
In addition to these normal sounds, a variety of other
sounds may be present but requires highly sensitive micro-
phone with lowest acoustic background noise level along
with filters to pick up these sounds. A third low frequency
sound, which may be heard at the beginning of the diastole,
is referred to as S3. A fourth sound may be heard in late
diastole during atrial contraction, is referred to as S4. These
sounds can be associated with heart murmurs, adventitious
sound, ventricular gallop and gallop rhythms. The S4 pro-
vides information about hypertension and acute myocardial
infarction.
The cardiac sounds SI, S2, S3, and S4 can be attributed
to specific cardiac activity. S1 is attributed to the onset of the
ventricular contraction (10-140 Hertz bands). S2 is attrib-
uted to closure of the semilunar valves (10-400 Hertz
bands). S3 may be attributed to ventricular gallop, which
may be heard during rapid filling (i.e. diastole) of the
ventricles, S4 may be attributed to atrial gallop, which may
be heard in late diastole, during atrial contraction. S3 and S4
are of very low intensity and can be heard externally when
amplified.
Other sounds may be heard from opening snaps of the
mitral valve or ejection sound of the blood in the aorta which
indicates valve malfunctions, such as stenosis or regurgita-
tion. Other high frequency murmurs can occur between the
two major heart sounds during systole or diastole. The
murmurs can be innocent but can also indicate certain
cardiovascular defects.
Continuous fetal heart monitoring is an important step to
evaluate the well-being of a fetus. The fetal heart rate may
indicate if the fetus is getting enough oxygen. Most of the
time ultrasound transducers are used for monitoring fetal
heart rate as conventional stethoscopes undesirably pick up
signals from maternal abdominal vessels. Due to abdominal
fat of the mother or fetal positioning, it may be difficult to
monitor fetal heart passively, so most of the time ultrasound
transducers are used where ultrasound pulses are radiated
towards the fetus and reflective pulses are used for moni-
toring. If enough reflective signals are not received, the
penetration depth of ultrasound pulses are increased which
may decrease quality and signal-to-noise ratio. The high
frequency ultrasound signals become attenuated due to
absorption, reflection, and scattering due to abdominal fat.
The infrasound signals have relatively very low attenuation
coefficient hence the signals are expected to be of high
quality with better signal to noise ratio and helpful to
gynecologists.
Many heart sounds are in a low-frequency band spectrum
with low intensity level and may require extremely sensitive
infrasonic microphone to acquire useful information that
cannot be perceived by the physician's ear. The passive
filtering may be useful to record low and high frequency
bands separately. The sounds are of short duration and
highly non-stationary but enable to measuring systolic and
diastolic time intervals, which may have diagnostic impor-
tance.
Accordingly, there is a need for a monitoring device that
overcomes the disadvantages presented by the prior art.
BRIEF SUMMARY OF THE INVENTION
An infrasonic stethoscope (or infrascope) or monitoring
physiological processes of a patient includes a microphone
4
capable of detecting acoustic signals in the audible fre-
quency bandwidth and in the infrasonic bandwidth. The
microphone has a body, which includes first and second
spaced apart openings. A body coupler is attached to the first
5 opening of the body to form a substantially air-tight seal,
wherein the body coupler is capable of engagement with the
patient to monitor physiological processes. A flexible tube is
attached to the body at the second opening in the micro-
phone. An earpiece is attached to the flexible tube. The body
10 coupler is capable of engagement with a patient to transmit
sounds from the patient to the microphone, and then to the
earpiece.
These and other features, advantages, and objects of the
present invention will be further understood and appreciated
15 by those skilled in the art by reference to the following
specification, claims, and appended drawings.
BRIEF DESCRIPTION OF THE SEVERAL
VIEWS OF THE DRAWINGS
20
The organization and manner of the structure and opera-
tion of the disclosed embodiments, together with further
objects and advantages thereof, may best be understood by
reference to the following description, taken in connection
25 with the accompanying drawings, which are not necessarily
drawn to scale, wherein like reference numerals identify like
elements in which:
FIG. 1 is perspective view of an embodiment of an
infrascope which can be used for external monitoring of a
30 patient;
FIG. 2 is a perspective view of the infrascope attached to
a catheter, for use in internal fetal monitoring of a patient;
FIG. 3 is a perspective view of a pair of infrascopes which
can be used in Doppler phonocardiography;
35 FIG. 4 is a graph showing bandwidths of heart sound;
FIG. 5 is a cross-sectional view of a microphone which
forms part of an infrascope of the present invention and of
a body coupler according to a first embodiment attached to
the microphone and which forms part of the infrascope of
40 the present disclosure;
FIG. 5A is a cross-sectional view of a body coupler
according to a second embodiment and which forms part of
the infrascope of the present disclosure;
FIG. 6 is a schematic view of a skeleton of a patient;
45 FIG. 7 is a flow chart regarding the process of how signals
from the infrascope are transmitted and analyzed;
FIGS. 8-17 are charts of infrascope signals collected at
locations A, P, T and M of FIG. 6 with reference to
electrocardiogram signals referred as ECG or EKG; and
50 FIGS. 18 and 19 show charts of infrascope data as
compared to ECG or EKG on two different subjects from 1
Hz through 1000 Hz.
DETAILED DESCRIPTION OF THE
55 INVENTION
While the disclosure may be susceptible to embodiment in
different forms, there is shown in the drawings, and herein
will be described in detail, a specific embodiment with the
60 understanding that the present disclosure is to be considered
an exemplification of the principles of the disclosure, and is
not intended to limit the disclosure to that as illustrated and
described herein. Therefore, unless otherwise noted, features
disclosed herein may be combined together to form addi-
65 tional combinations that were not otherwise shown for
purposes of brevity. It will be further appreciated that in
some embodiments, one or more elements illustrated by way
US 9,867,591 B2
5
of example in a drawing(s) may be eliminated and/or
substituted with alternative elements within the scope of the
disclosure.
As shown in FIG. 1, an infrascope 20 is provided to
monitor physiological processes of a patient. The infrascope
20 detects signals in a bandwidth from 0.03 Hertz through
1000 Hertz, or alternatively 0.03 through 500 Hertz. These
bandwidths contains signals which are audible and inaudible
to the human ear. The infrascope 20 has multiple applica-
tions to measure a variety of human physiological processes,
including, but not limited to, cardiac monitoring, external
fetal monitoring, internal fetal monitoring, stress phonocar-
diography testing, Doppler phonocardiography, biometric
identification and polygraphs. The bandwidth of audible and
inaudible sounds produced by cardiac activity are shown in
FIG. 4, which demonstrates energy distribution (dynes/cm2)
as a function of frequency (Hz).
The infrascope 20 contains a microphone 22, a body
coupler 24 or 24a attached to the microphone 22, a flexible
tube 26 attached to the microphone 22 and earpiece 28
connected to the flexible tube 26. For internal fetal moni-
toring, as shown in FIG. 2 and as further described herein,
the body coupler 24a is used and the microphone 22 is
further connected to a catheter 23 via the body coupler 24a.
The microphone 22 is substantially the same as the
microphone described in U.S. Pat. No. 8,401,217, with the
modifications described herein. The contents of U.S. Pat.
No. 8,401,217 is incorporated by reference in its entirety.
The microphone 22 is best shown in FIG. 5 and includes
a cup-like body 30, a cup-like support plate 32, an insulating
member 34, a conductor 36, a backplate 38, a membrane 40
and a low-noise preamplifier board 42.
The body 30 has a cylindrical side wall 44 having a
proximal end and a distal end, an end wall 46 at the proximal
end of the body 30, and a connection port 48 extending
proximally from the end wall 46. The body 30 is formed of
metal, such as a stainless steel or aluminum. The side wall
44 and the end wall 46 define an internal cavity 50 within the
body 30. The distal end of the body 30 is open such that an
aperture 52 is defined in the body 30. A thread form 54 is
provided on the exterior surface of the side wall 44 at the
distal end. The end wall 46 substantially closes the proximal
end of the body 30, with the exception of an aperture 56
therethrough, and may extend perpendicularly relative to the
side wall 44. The aperture 56 may be centrally located in the
end wall 46 and is communication with the connection port
48. The connection port 48 extends proximally from the end
wall 46 and has a passageway 58 therethrough which is
communication with the cavity 50 via the aperture 56. The
exterior surface of the connection port 48 has a thread form
60 thereon. An aperture 62 is provided through the side wall
44 at a position spaced from the proximal end of the side
wall 44.
The support plate 32 is attached to the internal surface of
the side wall 44 and seats within the cavity 50. The support
plate 32 is formed of metal, and has a circular base wall 64
which spans the diameter of the side wall 44 and is parallel
to the end wall 46, and a depending side wall 66 which
extends distally from the base wall 64. The side wall 66
terminates in a free end. The side wall 66 engages against the
internal surface of the side wall 44 of the body 30, such that
the free end of the side wall 66 is proximate to the distal end
of the body 30, and the base wall 64 is spaced from the distal
end of the body 30. The support plate 32 is affixed to the
body 30 by suitable means, such as welding, in such a way
that whole assembly can be connected to the ground of
preamplifier board 42. As a result of this arrangement, a
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distal chamber 68 is formed between the base wall 64 and
the distal end of the body 30, and a proximal chamber 70 is
formed between the base wall 64 and the proximal end of the
body 30. The base wall 64 has an aperture 72 therethrough,
5 which may be centrally located. The base wall 64 also has
at least one aperture 74 or slot therethrough to allow air to
flow from the distal chamber 68 to the proximal chamber 70.
The insulating member 34, which may be formed of
plastic, ceramic, wood or any suitable insulating material,
io seats within the aperture 72 in the support plate 32 and is
used to electrically isolate the conductor 36, the backplate 38
and the preamplifier board 42 from the support plate 32. As
shown, the insulating member 34 has a central portion 76
which extends through the aperture 72, a proximal portion
15 78 which extends radially outwardly from the central portion
76 on the distal side of the base wall 64, and a distal portion
80 which extends radially outwardly from the central portion
76 on the proximal side of the base wall 64. A passageway
82 extends through the central portion 76.
20 The backplate 38 is formed of a conducting material, and
is formed from a base wall 88 and may further be formed of
a proximal extending portion 90 which extends perpendicu-
larly from the base wall 88. The backplate 38 may be formed
of, for example, from conducting ceramics, brass, or stain-
25 less steel. A passageway 89 extends through the base wall
88, and extending portion 90 if provided, from its proximal
surface to its distal surface. A permanently polarized thin
polymer film 91 is coated on the distal surface of the
backplate 38. The polarized thin polymer film 91 operates
30 without the need for an external power supply. As described
in U.S. Pat. No. 8,401,217, the backplate 38 has a plurality
of spaced apart holes 92 therethrough (two holes are visible
in FIG. 5. The extending portion 90 engages against the
distal portion 80 of the insulating member 34, and is secured
35 to a distal end of the conductor 36, such that the backplate
38 and the conductor 36 are in electrical communication.
The base wall 88 of the backplate 38 is parallel to the base
wall 64 of the support plate 32. A slot 94 is defined between
the outer diameter of the backplate 38 and the side wall 44
40 of the body 30. The area between the backplate 38 and the
proximal end of the body 30 defines a backchamber.
The conductor 36 extends through the passageways 82, 89
and extends into the proximal chamber 70. The conductor 36
is electrically connected to backplate 38. As shown, the
45 conductor 36 is formed of a conducting rod or wire 84 which
extends through the passageways 82, 89, and a conductive
rod 86 extending proximally from the conducting rod or
wire 84 and the insulating member 34. If formed of two
components, the components are suitably connected to each
50 other to form an electrical connection. The rod or wire 84
and rod 86 may be formed of brass, or may be formed of
differing conductive materials. The proximal end of the
conductor 46 is proximate, to but spaced from, the end wall
46 such that a gap is defined therebetween.
55 The membrane 40 is formed of a flexible conductive
material and is seated at the distal free end of the side wall
66 of the support plate 32 such that the membrane 40 is
positioned within the distal chamber 68 and is proximate to,
but spaced from, the distal end of the body 30. The diameter
60 of the membrane 40 is selected so that the membrane 40
stays within side wall 66. The membrane 40 is parallel to the
end wall 46 of the body 30 and to the base wall 64 of the
support plate 32. As a result, the membrane 40 is in electrical
communication with the support plate 32. The tension of the
65 membrane 40 maybe less than about 400 Newton per meter.
The backplate 38 is proximate to, but spaced from the
membrane 40, such that an air gap 98 is formed between the
US 9,867,591 B2
7
membrane 40 and the backplate 38 to create a capacitor in
the microphone 22 as is described in U.S. Pat. No. 8,401,
217. As described in U.S. Pat. No. 8,401,217, the number,
locations and sizes of the holes 92, the size of the slot 94, and
the inner volume of the backchamber are selected such to
allow enough air flow to provide proper damping of the
motion of the membrane 40. As described in U.S. Pat. No.
8,401,217, the backchamber serves as a reservoir for the
airflow through the holes 92 in the backplate.
In an exemplary embodiment, the membrane 40 has a
diameter of approximately 1.05 inches (0.0268 meter). The
membrane 40 may have the following characteristics/dimen-
sions:
radius-0.0134 meter;
thickness=2.54x10-s meter;
density-8000 kilogram/meter3;
tension-400 N/meter;
surface density-0.1780 kilogram/meter2; and
stress=47.4045 PSI.
The microphone 22 may comprises an air layer which may
have the following characteristics/dimensions:
air gap=2.54x10-5 meter;
density=1.2050 kilogram/meter3;
viscosity=1.8x10-5 Pascal-second;
sound velocity through the air gap=290.2 meters per
second; and
gamma=l.4
The microphone 22 may also comprise a slot 94 which may
have the following characteristics/dimensions:
distance from the center of the backplate-0.0117 meter;
width-0.00351 meter;
depth-0.00114 meter; and
area-0.000258 meter.
The backplate 38 may define six holes 92, and each hole 92
may have the following characteristics/dimensions:
distance from center of backplate to center of
hole-0.00526 meter;
radius-0.002 meter;
depth-0.045 meter;
angle between two lines going from center of backplate to
either side edge of hole=43.5 degrees; and
area=1.26x10-5 meter.
The microphone 22 may also have the following further
characteristics/dimensions :
volume of the backchamber--5x 10-5 meter 3;
membrane mass-480 kilogram/meter4;
membrane compliance=3.2xIO" meters/Newton; and
air gap compliance=3.5x10-10 meters/Newton.
In one embodiment, the resonant frequency of the micro-
phone 22 may be 3108.01 Hertz.
The preamplifier board 42 is planar and extends radially
outwardly from the proximal end of the conductor 36. The
preamplifier board 42 is connected to the proximal end of the
conductor 36 by suitable means such that there is an elec-
trical connection between the preamplifier board 42 and the
conductor 36, such as a brass screw 99. The preamplifier
board 42 is parallel to the end wall 36 of the body 30, the
base wall 64 of the support plate 32 and the base wall 88 of
the backplate 38. The position of the preamplifier board 42
defines a first proximal chamber 100 which has a volume V1
between the preamplifier board 42 and the end wall 46 of the
body 30, and a second distal chamber 102 which has a
volume V2 between the preamplifier board 42 and the base
wall 64 of the support plate 32. A slot 104 is defined between
the outer diameter of the preamplifier board 42 and the side
wall 44 of the body 30 to allow air to flow from the distal
chamber 102 to the proximal chamber 100. In an embodi-
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ment, volume V1 is approximately 0.1287 cubic inch, and
volume V2 is approximately 0.6 cubic inch. The air can only
flow from the distal chamber 102 to the proximal chamber
100 through the slot 104. In an embodiment, this slot 104 has
5 a clearance distance between the outer diameter of the
preamplifier board 42 and the side wall 44 of approximately
0.025", which slot 104 extends around the preamplifier
board 42.
An electrical connection 106 extends through the aperture
io 62 in the side wall 44 and is sealed to the side wall 44 by
suitable means. The electrical connection 106 is electrical
communication with the preamplifier board 42 via wires
108, 110. The preamplifier board 42 is also electrically
connected to the body 30 via a wire 110, which provides a
15 ground to the preamplifier board 42. The preamplifier board
42 contains known components for measuring the capaci-
tance between the membrane 40 and the backplate 38, and
converting this measured capacitance into voltage.
The connection port 48 is connected to a distal end of the
20 flexible tube 26, which may be formed of latex or rubber,
which has an earpiece 28 at the proximal end of the tube 26.
Such a flexible tube 26 and earpiece 28, like a typical
stethoscope, are known in art for transmitting sound. The
flexible tube 26 is attached to the connection port 48, such
25 that there is no air exchange between the flexible tube 26 and
the body 30, and such that the passageway through the tube
26 is in communication with the distal chamber 100 via the
passageway 58 and aperture 56. When the earpiece 28 is
inserted into the ears of the medical personnel, this allows
30 substantially no air exchange between the cavity 50 of the
microphone 22 and the outside the microphone 22. The
length of the flexible tube 26 is adjusted so that maximum
audible sound is received at the earpiece 28, which are used
by medical personnel to hear the desired sounds in real time.
35 The combination of volumes V1 and V2 and the slot 104
around the preamplifier board 42 provide sufficient acoustic
resistance for pressure equalization, and lowers the low
frequency threshold. When the flexible tube 26 is connected
to the earpiece 28, due to increased acoustic resistance and
40 longer required period for pressure equalization, this lowers
the low -3 dB frequency to 0.03 Hertz.
As described herein, the microphone may differ from U.S.
Pat. No. 8,401,217 in that the body 30 is not completely
sealed in that a connection port 48 is provided for connecting
45 the microphone 22 to the flexible tube 26 and the earpiece
28, in that the preamplifier board 42 is mounted horizontally
in the body 30 to divide the backchamber into two lower
chambers 100 and 102 and that the preamplifier board 42 is
parallel to the membrane 40, rather than being positioned
50 vertically that is perpendicular to the membrane 40 as is
positioned in U.S. Pat. No. 8,401,217, and in that the grid of
U.S. Pat. No. 8,401,217 is eliminated and instead body 30
includes threads 54 for connection of the body coupler 24 or
24a to the distal end of the body 30.
55 The body coupler 24, 24a threadedly attaches to the
thread form 54 at the distal end of the body 30 such that there
is no air exchange between the body coupler 24, 24a and the
body 30. In one embodiment, as shown in FIG. 5, the body
coupler 24 is formed of an outer ring 114 which has a
60 flexible non-conductive diaphragm 116 attached thereto and
which spans the diameter of the ring 114. The outer ring 114
may be formed either of thermoplastic polyurethane elasto-
mers (TPU) or of closed cell polyurethane foam material
which can be made of different densities, and has an internal
65 thread form 118 for attachment of the outer ring 114 to the
distal end of the body 30. The TPU material is used when
full spectrum of acoustic signals are to be recorded from a
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heart and closed cell polyurethane foam material is used
only when infrasonic signals is to be recorded as this
material acts as a passive filter and audible sound is shunted
off. When attached, the membrane 40 of the microphone 22
and the diaphragm 116 of the body coupler is approximately
0.1 inch apart. The body coupler 24 is placed against the
body of the patient during the monitoring of the physiologi-
cal process. In another embodiment, as shown in FIG. 5A,
the body coupler 24a has a cup-like wall 120 having
opposite proximal and distal ends and which defines a cavity
126 therein, and a connection port 122 extending from the
distal end. The connection port 122 has a passageway 128
therethrough which is in fluid communication with the
cavity 126 by an aperture 130 through the wall 120. The
exterior surface of the connection port 122 may have a
thread form thereon. The proximal end of the wall 120 is
open and a thread form 124 is provided on the interior
surface of the wall 120. The wall 120 and connection port
122 are formed either of aluminum or brass. With this
second embodiment of the body coupler 24a, the proximal
end of the flexible catheter tube 23 is attached to the
connection port 122, and the thread form 124 engages with
the thread form 54 on the body 30 of the microphone 22. As
such, the connection between the catheter tube 23, the body
coupler 24a and the microphone 22 is sealed to prevent air
entrance therethrough. As is known, catheter tubes 23 have
opening(s) 25 at the end of the tube 23. The end of the tube
23 may be inserted into the bladder 132 of a patient to
provide internal fetal monitoring. The bladder 132 is proxi-
mate to the uterus 134 and sound, specifically infrasound,
transmission is conveyed from the uterus 134, to the bladder
132, to the catheter tube 23 via the opening(s) 25, and then
to the microphone 22.
As discussed herein, the preamplifier board 42 is installed
parallel to the base wall 54 and to the membrane 24. The slot
104 between the edge of the preamplifier board 42 and the
side wall 44 is small, for example 0.025", to increase
acoustic resistance. The combined volumes Vl and V2 and
the volume in the flexible tube 26 is 5x10-5 mete?. Because
of increased acoustic resistance, pressure equalization takes
longer which aids in lower —3 dB frequency to 0.03 Hertz.
In use, the body coupler 24 or catheter tube 23 detects
incident sound pressure from the heart, the uterus, or from
any other location of the body where it is placed. For
example as shown in FIG. 6, the body coupler(s) 24 may be
placed at locations A, P, T and/or M on the body of the
patient. The sound pressure excites the motion of the mem-
brane 40 within the microphone 22. The motion of the
membrane 40 changes the capacitance between the mem-
brane 40 and the backplate 38. This electrical signal travels
from the backplate 38, through the conductor 36 and to the
preamplifier board 42, thereby producing a proportional
output voltage at the preamplifier board 42. The preamplifier
board 42 is grounded via wire 112. The signal is sent from
the preamplifier board 42 through the sealed electrical
connection 106 to an electronics board which digitizes and
transfers the data wirelessly to a nearby computer. The
received signals are detected in the bandwidth of 0.03
through 1000 Hertz.
The microphone 22 provides damping of the motion of
the membrane 40 for flat frequency response over a desired
range by using the air gap 98 and the holes 92 in the
backplate 38. When the membrane 40 vibrates, the mem-
brane 40 compresses and expands the air layer in the air gap
98 and creates a reaction pressure, which opposes the motion
of the membrane 40. The reaction pressure generates airflow
which introduces damping primarily at two places: in the air
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gap 98 between the membrane 40 and the backplate 38, and
in the holes 92 in the backplate 38 which provide large
surface areas for viscous boundary layer damping.
As described in U.S. Pat. No. 8,401,217, in a 3 inch
5 diameter infrasonic microphone 22, the tension of the mem-
brane 40 may be less than about 1500 Newton per meter. For
example, where the radius of the membrane 40 is about
0.0342 meter, the tension of the membrane 40 may be less
than about 1000 Newton per meter. Further, the resonance
to frequency of the microphone 22 may be less than about 1000
Hertz. Still further, the volume of the backchamber may be
selected to produce a low-frequency air compliance that
exceeds the compliance of the membrane 40 by a factor of
15 at least 3. In one example, the radius of the membrane 40 is
about 0.0342 meter. In this example, the backplate 38
defines six holes 92, each having a radius of about 0.00302
meter. The holes 92 are evenly spaced along an imaginary
circle on the backplate 38 and a center of each hole 92 is
20 aligned with the imaginary circle. The center of the imagi-
nary circle is located coincident with a center of the back-
plate 38, and the radius of the imaginary circle is about
0.0105 meter. The width of the slot 94 is about 0.0144 meter
and the area of the slot 94 is about 0.00179 m2.
25 In an approximately 1.5 inch diameter infrasonic micro-
phone 22, where the radius of the membrane 40 is about
0.0134 meter, the tension of the membrane 40 may be less
than about 400 Newton per meter. Further, the resonance
frequency of the microphone 22 may be less than about 1500
3o Hertz. Still further, the volume of the backchamber may be
selected to produce a low-frequency air compliance that
exceeds the compliance of the membrane 40 by a factor of
at least 10. In another example, the radius of the membrane
40 is about 0.0134 meter. In this example, the radius of each
35 of the six holes 92 is about 0.002 meter and the radius of the
imaginary circle is about 0.0117 meter. The width of the slot
94 is about 0.00351 meter and the area of the slot 94 is about
0.000258 m2. The volume of the backchamber is about
0.00005 m3.
40 As shown in the block diagram of FIG. 7, the signals from
the infrascope 20 are digitized via an analog to digital
digitizer board 140. Once digitized, the signal is transmitted
wirelessly or by cable to workstation 142, such as a laptop
or personal computer. At 144, time history is plotted for data
45 collected at different locations of the patient such as at
locations A, T, P and M as shown in FIG. 6. The workstation
142 provides control, analysis and display of the recorded
data. MATLAB may also be used to process the data to
generate the real-time spectrograms using short-time Fourier
50 transform (STFT) spectrum of the corresponding data at 146
and 148. The time history and spectrogram of biological
signals is transferred by the Internet 150 to a remote work-
station 152, if desired, for observation and analysis.
Examples of such remote workstations 52 may be a remote
55 computer monitor, smartphone or tablet. The signals may be
sent via wired connection, or may be wirelessly transmitted,
such as by using commercially available Bluetooth module,
to PC or laptop for processing. The data is converted in
useful visual format also called spectrogram, which may be
6o helpful for physician to diagnose any abnormality. The
display of short term spectra is performed in real time, in
order to detect the presence of a short term event in the data.
FIGS. 8-17 show charts of infrascope signals collected at
locations A, P, T and M of FIG. 6 with reference to
65 electrocardiogram signals usually referred as ECG or EKG.
FIGS. 18 and 19 show charts of infrascope data as compared
to ECG or EKG on two different subjects from 1 Hz through
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1000 Hz. The ECG signals of both subjects are quite
different and infrascope signals also follow the trend of
ECG.
The infrascope 20 can be used for a stress phonocardiog-
raphy test. Some heart problems occur only during physical
activity. Stress phonocardiography test can be accomplished
using the signals from the infrascope 20 immediately before
and after walking on a treadmill or riding a stationary bike.
The infrascope 20 may be used for fetal heart monitoring
during pregnancy, labor, and delivery to keep track of the
heart rate of a fetus and the strength and duration of the
contractions of uterus. External fetal heart monitoring which
involves placing the body coupler 24 against the abdomen of
the patient, keeps track of the baby's heart rate while at rest
and while moving; measures the number of contractions and
how long contractions last during labor and delivery; deter-
mines if there is preterm labor. Internal fetal heart monitor-
ing, as shown in FIG. 2 and which uses the catheter 23 as
described herein, determines if the stress of labor is threat-
ening the baby's health; measures the strength and duration
of the labor contraction.
The infrascope 20 can be used for Doppler phonocardiog-
raphy as shown in FIG. 3. A Doppler phonocardiography can
be used to measure blood flow within the heart without an
invasive procedure. The left ventricular filling pressure and
blood flow can be estimated by using two infrascopes 20.
The infrascopes 20 can be placed at any desired location, for
example locations A, P, T and M, by using a mounting
structure 160 having adjustable rods 162 attached to the
microphones 22 to determine two dimensional velocity
estimation and imaging.
The infrascope 20 can be used for biometric identifica-
tion. Fingerprints have been used for identification for more
than 100 years, but using heartbeat for biometric identifi-
cation has some advantages such as convenience and secu-
rity. The heartbeat signatures can be extracted using either
ECG/EKG or by using the infrascope 20 at remote locations.
The security feature is preserved from the fact that a user's
ECG or acoustic signatures cannot be captured without a
person's consent. Another disadvantage of fingerprints are
that these can be replicated by using samples left behind.
The infrasonic bandwidth signals provide better and higher
signal to noise ratio values and another tool for biometric
identification.
The infrascope 20 can be used for polygraphs. Physi-
ological processes measured by polygraphs are; cardiovas-
cular, electrodenmal, and respiratory. The direction and
extent of cardiovascular reactivity may be different across
individuals in response to stimuli that may be considered
arousing. Electrodermal activity in terms of skin resistance
or conductance is measured by passing a current through the
skin. In response to controlled and relevant questions, varia-
tions from basal levels are called electrodermal or EDR
responses or electrodermal activity levels and is used for
polygraph interpretation. Variations in respiration which
also produce changes in heart rate and electrodermal activity
is monitored to determine of responses to relevant and
control questions are artifacts. Currently, the rate and depth
of respiration during polygraph are measured by changes
measured using strain gauges positioned on chest and abdo-
men. Extreme low frequency signal measurements can be
made by positioning the infrascope 20 at a subject's chest
and abdomen is a relatively inexpensive tool to measure
variation in respiratory and cardiovascular activity.
The infrascope 20 of the present disclosure enables medi-
cal personnel to look at the audible bandwidth as well as
infrasonic bandwidth, thus providing medical personnel
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with another tool to analyze physiological processes. The
infrascope 20 can be used for respiratory, cardiac, and for
fetal heart monitoring. The infrascope 20 enables physi-
ological process signals to be transferred to any place in the
5 world in real time. Ambulances can be equipped with the
infrascope 20 and medical personnel are able to obtain a
patient's physiological information in real time. The infra-
scope 20 is a relatively inexpensive tool to diagnose abnor-
mality at early stage.
10 The terms "patient" is used throughout the disclosure,
which includes humans and animals, as it is anticipated that
the present invention would also be capable of monitoring
physiological processes for veterinary practices.
All references disclosed herein are hereby incorporated by
15 reference in their entirety.
While particular embodiments are illustrated in and
described with respect to the drawings, it is envisioned that
those skilled in the art may devise various modifications
without departing from the spirit and scope of the appended
20 claims. It will therefore be appreciated that the scope of the
disclosure and the appended claims is not limited to the
specific embodiments illustrated in and discussed with
respect to the drawings and that modifications and other
embodiments are intended to be included within the scope of
25 the disclosure and appended drawings. Moreover, although
the foregoing descriptions and the associated drawings
describe example embodiments in the context of certain
example combinations of elements and/or functions, it
should be appreciated that different combinations of ele-
30 ments and/or functions may be provided by alternative
embodiments without departing from the scope of the dis-
closure and the appended claims.
What is claimed is:
35 1. An infrasonic stethoscope device for monitoring physi-
ological processes of a patient, said device comprising:
a body comprising an opening within a first end, a body
end wall at a second end opposite the first end, and a
body side wall extending between the first end and the
40 second end;
a body coupler attached to the first end and over the
opening of the body to form a substantially air-tight
seal, wherein the body coupler is capable of engage-
ment with the patient;
45 a cavity surrounded by the body end wall, the body side
wall and the body coupler;
a conductive backplate within the cavity and defining a
backchamber between the conductive backplate and the
body end wall;
50 a conductive membrane within the cavity, the conductive
backplate and the conductive membrane being spaced
apart from each other to form a capacitor; and
a preamplifier board in electrical connection with the
conductive backplate, the preamplifier board (i) being
55 capable of measuring a capacitance between the con-
ductive membrane and the conductive backplate and
converting the measured capacitance into a voltage
signal, (ii) being parallel to each of the conductive
backplate and the conductive membrane, and (iii)
60 defining first and second chambers within the body;
said device being capable of detecting acoustic signals in
a frequency range of 0.03 Hertz to about 1000 Hertz,
including being capable of detecting infrasonic acous-
tic signals in a frequency range of less than about 20
65 Hertz.
2. The device of claim 1, wherein (i) the conductive
backplate defines a plurality of holes, and (ii) a slot is present
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between an outer diameter of the conductive backplate and
an inner surface of the body side wall.
3. The device of claim 2, wherein locations and sizes of
the holes and a size of the slot are selected such that
membrane motion is substantially critically damped.
4. The device of claim 1, further comprising:
a conductive support plate mounted to the body, the
conductive support plate having a passageway and at
least one aperture therethrough;
an insulating member extending through the passageway
in the conductive support plate;
a conductive member extending through the insulating
member and extending therefrom, the conductive mem-
ber being electrically connected to the conductive back-
plate and to the preamplifier board,
wherein the conductive backplate is on one side of the
conductive support plate and the preamplifier board is
on an opposite side of the conductive support plate.
5. The device of claim 4, wherein the conductive back-
plate is seated on the insulating member.
6. The device of claim 1, wherein a slot is defined between
the preamplifier board and an inner surface of the body side
wall, the slot having a length of approximately 0.025".
7. The device of claim 1, wherein the first chamber has a
volume of approximately 0. 1287 cubic inch, and the second
chamber has a volume of approximately 0.6 cubic inch.
8. The device of claim 1, wherein the body coupler is
formed of an outer ring having a flexible, non-conductive
diaphragm attached thereto, and the outer ring is attached to
the body.
9. The device of claim 8, wherein the outer ring and the
body are threadedly connected.
10. The device of claim 1, further comprising a sealed
electrical connection extending though the body side wall,
said sealed electrical connection enabling electrical connec-
tion of said device to a remote device.
11. The device of claim 10, further comprising a digitizer
board remote from the body, said digitizer board being
capable of digitizing the voltage signal from the preamplifier
via the sealed electrical connection.
12. The device of claim 1, wherein the voltage signal is
digitized and electronically transmitted to a remote location.
13. The device of claim 12, wherein the voltage signal is
electronically transmitted by wire.
14. The device of claim 12, wherein the voltage signal is
electronically transmitted wirelessly.
15. The device of claim 12, wherein the voltage signal is
electronically transmitted in real time.
16. An infrasonic stethoscope device for monitoring
physiological processes of a patient, said device comprising:
a body comprising an opening within a first end, a body
end wall at a second end opposite the first end, and a
body side wall extending between the first end and the
second end;
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a cavity surrounded by the body end wall, the body side
wall and the body coupler;
a flexible, non-conductive diaphragm extending over the
opening and being capable of engagement with the
5 patient; and
a preamplifier board positioned within the cavity and
being parallel to the flexible, non-conductive dia-
phragm;
said device being capable of detecting acoustic signals in
10 
a frequency range of less than about 20 Hertz.
17. The device of claim 16, further comprising:
a conductive membrane within the cavity, and positioned
between the flexible, non-conductive diaphragm and
the preamplifier board; and
a conductive backplate within the cavity and positioned
15 between the conductive membrane and the preamplifier
board, the conductive membrane and the conductive
backplate being spaced apart from each other to form a
capacitor.
18. The device of claim 17, further comprising:
20 a conductive support plate mounted to the body, the
conductive support plate having a passageway and at
least one aperture therethrough;
an insulating member extending through the passageway
in the conductive support plate; and
25 a conductive member extending through the insulating
member and extending therefrom, the conductive mem-
ber being electrically connected to the conductive back-
plate and to the preamplifier board,
wherein the conductive backplate is on one side of the
30 conductive support plate and the preamplifier board is
on an opposite side of the conductive support plate.
19. An infrasonic stethoscope for monitoring physiologi-
cal processes of a patient, comprising:
a microphone capable of detecting both audible and
35 infrasonic acoustic signals in a frequency range of 0.03
Hertz to about 500 Hertz, inclusive of acoustic signals
in an infrasonic frequency range of less than about 20
Hertz, the microphone comprising a body having a first
and second spaced apart openings and containing a
40 preamplifier board defining first and second chambers
within the body, the preamplifier board being config-
ured to output a voltage signal indicative of a measured
capacitance within the microphone;
a body coupler attached to the first opening of the body to
45 form a substantially air-tight seal, wherein the body
coupler is capable of engagement with the patient;
a flexible tube attached to the body at the second opening;
and
an earpiece attached to the flexible tube.
50 20. The infrasonic stethoscope of claim 19, further com-
prising a conductive membrane positioned within the body,
and having a radius of 0.0134 meters and a tension of less
than 400 Newtons per meter.
